IBM announced it is offering the IBM Db2 Developer Extension for Visual Studio (VS) Code-now generally available. Developers live in VS Code, but Db2 development often means switching tools to set up ...

From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...

The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...

Psybergate is an IT company that builds bespoke software solutions and provides highly skilled resources to its clients. We are looking for a Senior Database Developer to join our client on a remote ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Recently we were introduced to OpenClaw, an AI that allows users to create their own agents to control apps like email, Spotify and home controls. Now, Sam Altman has announced that OpenAI has ...

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion its initial public offering in the United States. The Somerville, ...

Roche has posted a mixed set of data from two clinical trials of its anti-IL-33/ST2 antibody astegolimab in chronic obstructive pulmonary disease (COPD), casting a shadow over the programme. On the ...